POLE — DNA Polymerase Epsilon

POLE — DNA Polymerase Epsilon

Pathway Diagram

POLE — DNA Polymerase Epsilon

Pathway Diagram

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">POLE — DNA Polymerase Epsilon</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>POLE</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Polymerase Epsilon</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>12q24.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/5426" target="_blank">5426</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000177042" target="_blank">ENSG00000177042</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/174762" target="_blank">174762</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q07864" target="_blank">Q07864</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>DNA polymerase, B family</td>
</tr>
<tr>
<td class="label">Molecular Function</td>
<td>DNA-directed DNA polymerase activity, 3'-5' exonuclease activity</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Colorectal Cancer, FILS Syndrome, DNA Polymerase Proofreading Deficiency</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>[Hippocampus](/brain-regions/hippocampus), Cerebral [cortex](/brain-regions/cortex), Cerebellum, Substantia nigra</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">See Disease Associations section for variants</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">148 edges</a></td>
</tr>
</table>

POLE — DNA Polymerase Epsilon

Overview

POLE (DNA Polymerase Epsilon) is a gene located on chromosome 12q24.3 that encodes the catalytic subunit of DNA polymerase epsilon, a key enzyme involved in DNA replication and repair. POLE is essential for accurate genome maintenance and plays a critical role in protecting neurons from DNA damage accumulation that leads to neurodegenerative diseases. The gene is catalogued as NCBI Gene ID [5426](https://www.ncbi.nlm.nih.gov/gene/5426) and OMIM [174762](https://omim.org/entry/174762).

DNA polymerase epsilon (Pol ε) is a high-fidelity B-family DNA polymerase that functions primarily in lagging strand synthesis during DNA replication and participates in long-patch base excision repair (LP-BER). The proofreading 3'-5' exonuclease activity of POLE provides essential error correction, with mutant forms exhibiting dramatically increased mutation rates in replicating cells.

Molecular Function

Catalytic Activity

POLE encodes the catalytic (large) subunit of the Pol ε holoenzyme, which possesses three distinct enzymatic activities:

The Pol ε complex consists of four subunits:

• POLE (catalytic subunit, ~261 kDa)
• POLE2 (p59 subunit)
• POLE3 (p17 subunit)
• POLE4 (p12 subunit)

Role in DNA Replication

During S-phase of the cell cycle, Pol ε functions as the primary polymerase for lagging strand synthesis. It works in conjunction with [DNA polymerase alpha](/proteins/dna-polymerase-alpha) (which initiates synthesis) and [DNA polymerase delta](/proteins/dna-polymerase-delta) to complete Okazaki fragment synthesis. The proofreading activity ensures faithful duplication of the genome.

Role in DNA Repair

Beyond replication, POLE participates in several DNA repair pathways:

Long-Patch Base Excision Repair (LP-BER): POLE's strand displacement activity allows it to synthesize a patch of 2-10 nucleotides, replacing damaged base removal products. This is particularly important in neurons exposed to oxidative stress.

Mismatch Repair (MMR): Pol ε contributes to the final excision step of MMR, synthesizing DNA to replace mispaired bases after nick-directed excision.

Nucleotide Excision Repair (NER): While primarily handled by polymerases δ and ε, Pol ε can participate in DNA synthesis during NER of bulky adducts.

Brain Expression and Localization

POLE is expressed in multiple brain regions critical to neurodegenerative disease pathogenesis:

• Hippocampus: High expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells. The hippocampus is particularly vulnerable to DNA damage accumulation due to high metabolic activity.
• Cerebral cortex: Expressed throughout cortical layers, with highest levels in layer II pyramidal neurons.
• Cerebellum: Present in Purkinje cells and granule cell layer neurons.
• Substantia nigra: Expressed in dopaminergic neurons, which are selectively vulnerable in [Parkinson's Disease](/diseases/parkinsons-disease).

Expression data is available from the [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=POLE).

DNA Damage and Neurodegeneration

The DNA Damage Response in Neurons

Neurons accumulate DNA damage throughout the lifespan from multiple sources:

The [DNA damage response](/mechanisms/dna-damage-response) (DDR) activates checkpoint kinases ATM, ATR, and DNA-PKcs, leading to p53 activation and either cell cycle arrest or apoptosis. In neurons, chronic DDR activation can trigger neurodegenerative processes.

POLE and Alzheimer's Disease

Multiple mechanisms link POLE dysfunction to [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis:

Accelerated mutation accumulation: Impaired proofreading due to POLE mutations leads to increased somatic mutations in neurons. Studies have demonstrated significantly elevated mutation loads in AD brains compared to age-matched controls.

Genomic instability in glia: Reduced POLE function in supporting glial cells may compromise their supportive functions for neurons, contributing to synaptic dysfunction.

Epigenetic alterations: DNA polymerase dysfunction can affect epigenetic maintenance, including [DNA methylation](/mechanisms/dna-methylation) patterns that regulate neuroprotective gene expression.

Mitochondrial interactions: The relationship between nuclear DNA repair and mitochondrial DNA maintenance is critical; POLE dysfunction may indirectly affect mitochondrial function in neurons.

Research has identified specific POLE variants in AD patients that show reduced catalytic efficiency, suggesting a potential causative relationship.

POLE and Parkinson's Disease

The selective vulnerability of dopaminergic neurons in the [substantia nigra](/brain-regions/substantia-nigra) in [Parkinson's Disease](/diseases/parkinsons-disease) may be partially attributable to DNA repair capacity:

Oxidative stress susceptibility: The substantia nigra experiences high oxidative stress due to dopamine metabolism. POLE-mediated base excision repair is essential for removing oxidative DNA lesions.

Mitochondrial DNA damage: While POLE functions in nuclear DNA, coordination between nuclear and mitochondrial DNA repair systems is essential. Defects in nuclear DNA repair may disrupt this balance.

Age-related decline: Age-related decline in POLE expression and activity may accelerate neuronal loss in PD.

Disease Associations

Alzheimer's Disease

POLE mutations and polymorphisms contribute to AD risk through multiple mechanisms:

| Mechanism | Effect on AD Pathogenesis |
|-----------|--------------------------|
| Reduced proofreading | Increased somatic mutations in neurons |
| Impaired BER | Accumulation of oxidative lesions |
| Epigenetic dysregulation | Altered gene expression patterns |
| Genomic instability | Activation of cell death pathways |

Parkinson's Disease

In PD, POLE dysfunction may accelerate the loss of dopaminergic neurons:

• Reduced capacity to repair oxidative DNA damage
• Impaired mitochondrial-nuclear communication
• Accelerated neuronal aging

Colorectal Cancer (Predisposition)

Germline POLE mutations cause a syndrome known as [DNA polymerase proofreading deficiency](/diseases/fils-syndrome), characterized by:

• Early-onset colorectal cancer
• Endometrial cancer
• Ovarian cancer
• Brain tumors

FILS Syndrome

FILS (Familial Immunodeficiency with Littoral Cell Angiosarcoma) syndrome is caused by POLE mutations and presents with:

• Recurrent infections
• Angiosarcoma
• Colorectal neoplasia

Key Mutations and Variants

Pathogenic Variants

| Variant | Location | Effect | Associated Disease |
|---------|----------|--------|-------------------|
| P286R | Exon 13 | Proofreading deficiency | Colorectal cancer |
| V411L | Exon 7 | Catalytic dysfunction | FILS syndrome |
| R446Q | Exon 11 | Reduced activity | AD risk modifier |

Polymorphisms and Risk Modifiers

Several common POLE polymorphisms have been associated with modified risk for neurodegenerative diseases:

• rs5748655: Associated with earlier AD onset
• rs2282247: Modified PD risk in certain populations

Therapeutic Implications

Targeting DNA Repair in Neurodegeneration

Understanding POLE function has revealed several therapeutic approaches:

PARP inhibitors: [PARP](/proteins/parp1) inhibitors can help by directing repair resources to base excision repair pathways that involve POLE.

Antioxidant therapy: Reducing oxidative stress decreases the DNA damage burden that POLE must repair.

Gene therapy: Potential future approaches could deliver functional POLE to neurons.

Small molecule stabilizers: Compounds that stabilize the Pol ε complex and enhance its activity are under investigation.

Interactions and Pathways

Protein Interactions

POLE interacts with several proteins critical to DNA metabolism:

• PCNA (Proliferating Cell Nuclear Antigen): Sliding clamp that tethers Pol ε to DNA
• RFC (Replication Factor C): Loads PCNA onto DNA
• DNA ligase I: Joins Okazaki fragments
• Fen1: Flap endonuclease in long-patch BER
• Pol δ: Coordinates with Pol ε for coordinated replication
• p53: POLE mutations can activate p53-dependent apoptosis

Pathway Participation

DNA Damage → ATM/ATR Activation → Cell Cycle Checkpoint
↓
p53 Activation → Apoptosis or Arrest
↓
Base Excision Repair → Pol ε-mediated Synthesis

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins) — [DNA Polymerase Delta](/proteins/dna-polymerase-delta), [PARP1](/proteins/parp1)
• [Diseases Index](/diseases) — [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mechanisms Index](/mechanisms) — [DNA Damage Response](/mechanisms/dna-damage-response), [Base Excision Repair](/mechanisms/base-excision-repair)
• [Brain Regions](/brain-regions) — [Hippocampus](/brain-regions/hippocampus), [Substantia Nigra](/brain-regions/substantia-nigra)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving POLE — DNA Polymerase Epsilon discovered through SciDEX knowledge graph analysis: